raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:603

Distal myopathy, Welander type

Synonyms: WDM

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

A rare distal myopathy characterized by weakness in the distal upper extremities, usually finger and wrist extensors which later progresses to all hand muscles and distal lower extremity, primarily in toe and ankle extensors.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDistal myopathy, Welander typeWDM
frMyopathie distale type Welander= en
deMyopathie, distale, Typ Welander= en
esMiopatía distal tipo Welander= en
itMiopatia distale tipo Welander= en
nlDistale myopathie, Welander-type= en
ptMiopatia distal de Welander
plMiopatia dystalna, typ Welandera= en
csDistální myopatie, Welanderové typ= en
ukДистальна міопатія, тип Веландера= en
zhWelander远端型肌营养不良症= en
trDistal miyopati, Welander tipi= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM604454Evalidated
ICD-10G71.0NTBTattributedvalidated
ICD-118C75NTBTindexvalidated
MONDO0011466Evalidated
UMLSC0221054Evalidated
GARD5552Evalidated
MedDRA10078052Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

3 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TIA1Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:11802ENSG000001160016035182p13.3TIA1 cytotoxic granule associated RNA binding protein23348830[PMID]_23401021[PMID]
SQSTM1Modifying germline mutation inAssessedHGNC:11280ENSG000001610116015305q35.3sequestosome 129457785[PMID]
TIA1Modifying germline mutation inAssessedHGNC:11802ENSG000001160016035182p13.3TIA1 cytotoxic granule associated RNA binding protein29457785[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence>1 / 1000100 / 100 000SwedenValue and classValidatedDOI:https://doi.org/10.1016/S0960-8966(02)00116-5[OTHER]_ [EXPERT]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2019-07-10
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0008959Distal upper limb muscle weakness
HP:0003458EMG: myopathic abnormalities
HP:0009027Foot dorsiflexor weakness
HP:0008954Intrinsic hand muscle atrophy
HP:0003198Myopathy
HP:0009077Weakness of long finger extensor muscles
Frequent (79-30%)
HP:0002312Clumsiness
HP:0007149Distal upper limb amyotrophy
HP:0001288Gait disturbance
HP:0008180Mildly elevated creatine kinase
HP:0003805Rimmed vacuoles
HP:0003376Steppage gait
Excluded (0%)
HP:0001638Cardiomyopathy

Run the differential on the 6 obligate / very frequent terms

Annotation source: 10482271[PMID]_23401021[PMID]_23348830[PMID]

7

Sources for this card